silybin has been researched along with Carcinoma, Transitional Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Chen, Y; Guo, P; He, D; Jia, J; Jin, B; Li, F; Ma, Z; Sun, Y; Tang, X; Wang, K; Wang, X; Yang, C; Zeng, J | 1 |
| Chen, Y; He, D; Li, L; Sun, Y; Wang, X; Wang, Z; Wu, K; Xue, Y; Yang, Z; Zeng, J; Zhang, D; Zhang, G; Zhu, G | 1 |
| Agarwal, C; Agarwal, R; Glode, LM; Shroyer, KR; Singh, RP; Tyagi, AK | 1 |
| Agarwal, C; Agarwal, R; Glode, LM; Harrison, G; Tyagi, A | 1 |
| Agarwal, R; Mohan, S; Sharma, G; Singh, RP; Tyagi, A | 1 |
5 other study(ies) available for silybin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Topics: Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Silybin; Transforming Growth Factor beta1; Urinary Bladder Neoplasms | 2018 |
Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria.
Topics: Administration, Intravesical; Animals; Antioxidants; Apoptosis; Apoptosis Inducing Factor; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Survival; Cytochromes c; Down-Regulation; Female; High-Temperature Requirement A Serine Peptidase 2; Humans; Inhibitor of Apoptosis Proteins; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Mitochondrial Proteins; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Silybin; Silymarin; Survivin; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
Topics: Apoptosis; Carcinoma, Transitional Cell; Caspases; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Papilloma; RNA, Messenger; Silybin; Silymarin; Survivin; Urinary Bladder Neoplasms | 2003 |
Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Topics: Apoptosis; Carcinoma, Transitional Cell; Caspase 3; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclins; Humans; Poly(ADP-ribose) Polymerases; Silybin; Silybum marianum; Silymarin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2004 |
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Microtubule-Associated Proteins; Neovascularization, Pathologic; Repressor Proteins; Silybin; Silymarin; Survivin; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2008 |